DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: TREATMENTS
       *****************************************************
       #Post#: 4508--------------------------------------------------
       (Abst.) Effectiveness of cladribine compared to fingolimod, nata
       lizumab, ocrelizumab, alemtuzumab...
       By: agate Date: August 7, 2024, 12:59 am
       ---------------------------------------------------------
       From PubMed (August 2, 2024)--"Effectiveness of cladribine
       compared to fingolimod, natalizumab, ocrelizumab, and
       alemtuzumab in relapsing-remitting multiple sclerosis":
  HTML https://pubmed.ncbi.nlm.nih.gov/39087208/
       *****************************************************